Invivyd, Inc. announced that Laura Walker, Ph.D., the company's chief scientific officer and co-founder, decided to leave the company to pursue other opportunities. The management team has initiated a search process to identify her replacement. Until a permanent successor is named, Invivyd team member Lukas Dillinger, Ph.D., has been appointed as interim Head of Discovery and Pre-Clinical.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.32 USD | +5.94% | -13.89% | -40.99% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.99% | 261M | |
-0.41% | 103B | |
+3.57% | 96.73B | |
+1.66% | 21.31B | |
-16.13% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-23.30% | 13.68B | |
+5.81% | 13.44B | |
+22.74% | 10.98B |
- Stock Market
- Equities
- IVVD Stock
- News Invivyd, Inc.
- Invivyd, Inc. Announces Executive Changes